Approach to Patients with Stinging Insect Allergy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31757231.
- Also identified by DOI 10.1016/j.mcna.2019.08.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stinging insect allergy is uncommon but can be life threatening. Diagnosis requires clinical history and confirmative skin or blood testing by an allergist. Baseline serum tryptase level can be used to stratify risk. Treatment is supportive for all reactions except for anaphylaxis, which is treated with intramuscular epinephrine, recumbent posture, and adjunct measures such as IV fluids, and oxygen. Venom immunotherapy is most effective for long-term management in patients with a history of anaphylaxis. Venom immunotherapy rapidly reduces the risk of sting anaphylaxis by up to 98% and maintenance treatment can be stopped after 5 years in most cases.
Medical subject headings
- Anaphylaxis
- Epinephrine
- Hypersensitivity
- Insect Bites and Stings